Vu Truong
Chief Executive Officer bei ARIDIS PHARMACEUTICALS, INC.
Vermögen: 57 514 $ am 31.03.2024
Profil
Vu L.
Truong is the founder.
He founded Aridis Pharmaceuticals, Inc. in 2003 and currently holds the title of Director, Chief Executive & Scientific Officer.
He also worked as a Principal at MedImmune LLC.
Dr. Truong has an undergraduate degree from Brandeis University and a doctorate degree from The Johns Hopkins University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.11.2023 | 737 353 ( 1,65% ) | 57 514 $ | 31.03.2024 |
Aktive Positionen von Vu Truong
| Unternehmen | Position | Beginn |
|---|---|---|
| ARIDIS PHARMACEUTICALS, INC. | Chief Executive Officer | 01.01.2014 |
Ehemalige bekannte Positionen von Vu Truong
| Unternehmen | Position | Ende |
|---|---|---|
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - |
Ausbildung von Vu Truong
| Brandeis University | Undergraduate Degree |
| The Johns Hopkins University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARIDIS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
